Furthermore, increased levels of PD-1 on CD4+ cells have been observed in MM patients with persistent minimal residual disease (MRD) and at relapse compared with T cells of first diagnosed MGUS and MM patient (42). This evidence concerns the gene PDCD1 and Miyoshi myopathy.